NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · GRUSF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Grown Rogue International Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Grown Rogue International Inc.’s next earnings report is currently expected on Nov 12, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Grown Rogue International Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Grown Rogue International Inc., operating through its subsidiary entities, focuses on the cultivation and retail of cannabis products across the United States. Its diverse product portfolio includes a variety of cannabis flower, such as indica, sativa, and hybrid strains, alongside edibles, vaporization cartridges, pre-rolled joints, and concentrated cannabis forms. The company's merchandise is distributed and sold primarily through licensed dispensaries. Grown Rogue International Inc.'s corporate headquarters are located in Medford, Oregon.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:42 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2024 | Nov 14, 2024 | -$0.00 | $6.99M+81.44% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$275.20+$4.16 (+1.53%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$290.97+$4.98 (+1.74%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.55% below the high.
$6.43+$0.02 (+0.31%)
Green Thumb Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.35% below the high.
CA$0.69-CA$0.02 (-2.82%)
TerrAscend Corp.’s quoted price sits in the lower half of its reported 52-week range, 65.5% below the high.
$0.53+$0.01 (+2.72%)
Jushi Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 41.69% below the high.
CA$0.20CA$0.00 (0.0%)
Leef Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
CA$0.02CA$0.00 (0.0%)
Red White & Bloom Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
